Vicarious Surgical Inc.
NYSE:RBOT
12 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 3.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.524 | 0.521 | 0.525 | 0.447 | 0.641 | 0.637 | 0.595 | 0.539 | 0.186 | 0.185 | 0.126 | 0.084 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | -0.524 | -0.521 | 2.925 | -0.447 | -0.641 | -0.637 | -0.595 | -0.539 | -0.186 | -0.185 | -0.126 | -0.084 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0.848 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 10.8 | 10.4 | 9.447 | 7.943 | 13.04 | 12.714 | 13.356 | 11.877 | 12.12 | 10.055 | 9.848 | 9.296 | 5.189 | 4.008 | 3.607 | 2.965 | 2.504 | 2.31 | 2.017 |
| General & Administrative Expenses
| 5.747 | 5.592 | 5 | 5.87 | 6.911 | 7.078 | 6.999 | 6.895 | 8.13 | 7.76 | 6.93 | 7.292 | 2.53 | 2.279 | 1.398 | 0.734 | 0.475 | 0.577 | 0.542 |
| Selling & Marketing Expenses
| 1.208 | 1.197 | 1.141 | 1.203 | 1.401 | 1.666 | 1.96 | 1.838 | 1.912 | 1.311 | 1.402 | 1.583 | 0.842 | 0.325 | 0.226 | 0.085 | 0.362 | 0.181 | 0.233 |
| SG&A
| 6.955 | 6.789 | 6.141 | 7.073 | 8.312 | 8.744 | 8.959 | 8.733 | 10.042 | 9.071 | 8.332 | 8.875 | 3.372 | 2.604 | 1.624 | 0.819 | 0.837 | 0.758 | 0.775 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 17.755 | 17.713 | 15.588 | 15.016 | 21.352 | 21.458 | 22.315 | 20.61 | 22.162 | 19.126 | 18.18 | 18.171 | 8.561 | 6.612 | 5.231 | 3.784 | 3.341 | 3.068 | 2.792 |
| Operating Income
| -17.755 | -17.713 | -16.109 | -15.541 | -21.352 | -21.458 | -22.315 | -20.61 | -22.162 | -19.126 | -18.18 | -18.171 | -8.561 | -6.612 | -5.231 | -3.784 | -3.341 | -3.068 | -2.792 |
| Operating Income Ratio
| 0 | 0 | 0 | -4.505 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.664 | 2.508 | -0.892 | 2.43 | 5.648 | 6.124 | -4.607 | 9.43 | -2.575 | 17.673 | 60.707 | 59.961 | -36.563 | -0.026 | 0 | 0 | 0 | 0.021 | 0.089 |
| Income Before Tax
| -17.091 | -15.205 | -17.001 | -13.111 | -15.704 | -15.334 | -26.922 | -11.18 | -24.737 | -1.453 | 42.527 | 70.08 | -65.479 | -6.638 | -5.231 | -3.784 | -3.341 | -3.047 | -2.703 |
| Income Before Tax Ratio
| 0 | 0 | 0 | -3.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0.478 | -4.148 | -0.447 | -1.043 | 5.638 | -8.709 | 3.038 | 0.029 | -60.728 | -59.972 | 56.887 | 0.026 | -1.657 | -0.001 | -0.001 | 0 | 0 |
| Net Income
| -17.091 | -15.205 | -17.001 | -13.111 | -15.704 | -15.334 | -32.56 | -2.471 | -27.775 | -1.453 | 103.255 | 70.08 | -65.479 | -6.638 | -5.231 | -3.784 | -3.341 | -3.047 | -2.703 |
| Net Income Ratio
| 0 | 0 | 0 | -3.8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -2.9 | -2.59 | -2.91 | -2.25 | -3.04 | -3.63 | -7.75 | -0.6 | -6.84 | -0.36 | 24.06 | 17.67 | -21.35 | -2.4 | -1.8 | -1.31 | -1.17 | -0.55 | -0.49 |
| EPS Diluted
| -2.9 | -2.59 | -2.91 | -2.25 | -3.04 | -3.63 | -7.75 | -0.6 | -6.84 | -0.36 | 24.3 | 17.67 | -21.32 | -2.27 | -1.8 | -1.31 | -1.17 | -0.55 | -0.49 |
| EBITDA
| -16.584 | -14.681 | -16.48 | -12.564 | -15.256 | -14.692 | -26.284 | -10.474 | -24.167 | -1.238 | 42.741 | 42.297 | -45.009 | -6.548 | -5.19 | -3.738 | -3.303 | -3.03 | -2.757 |
| EBITDA Ratio
| 0 | 0 | 0 | -4.352 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |